Log in

2137 Brii Biosciences Limited HKEX · China

Brii Biosciences (2137) news

Brii Biosciences Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2137, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Brii Biosciences news

We have not published a story on Brii Biosciences yet. When there is news, it will appear here.

Questions about Brii Biosciences

What is the ticker symbol of Brii Biosciences?

Brii Biosciences Limited trades under the ticker 2137 on HKEX.

Where is Brii Biosciences listed?

Brii Biosciences Limited is listed on HKEX. Our directory also records these other listings: GETTEX:7SS.

Which country or territory is Brii Biosciences listed under?

Our directory records Brii Biosciences Limited under China.

What does Brii Biosciences do?

Our directory classifies Brii Biosciences Limited as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Brii Biosciences?

The ISIN recorded for Brii Biosciences Limited is KYG1645A1094.

Does aibio.space cover Brii Biosciences?

aibio.space lists Brii Biosciences Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Brii Biosciences?

Companies in our directory listed in the same country and business area as Brii Biosciences: TransThera Sciences (Nanjing)., Sichuan Kelun Pharmaceutical Co., Zhejiang Laifual Drive Co., JW (Cayman) Therapeutics Co., XtalPi Holdings, Hebei Changshan Biochemical Pharmaceutical Co..

Investor discussion: Brii Biosciences

Members talk about Brii Biosciences (2137). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Brii Biosciences, newest first. Each line links the filing it comes from.

  1. Legal

    Legal proceedings: INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS. Source

  2. Financings

    Share or debt issue: (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; AND (5) NOTICE OF ANNUAL GENERAL MEETING. Source

  3. Legal

    Legal proceedings: INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS. Source

  4. Financings

    Share or debt issue: (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; AND (5) NOTICE OF ANNUAL GENERAL MEETING. Source

  5. Mergers

    Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO NOMINEE DESIGNATION AGREEMENT. Source

  6. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RELATION TO NOMINEE DESIGNATION AGREEMENT. Source

Press releases

Headlines of Brii Biosciences's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    VOLUNTARY ANNOUNCEMENT Launch of BRiSC, an siRNA Therapeutics Discovery Platform

  2. HKEXnews

    GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS

  3. HKEXnews

    Notification Letter and Request Form for Non-registered Shareholders

  4. HKEXnews

    Notification Letter and Change Request Form for Registered Shareholders

  5. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

  6. HKEXnews

    INSIDE INFORMATION Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B

  7. HKEXnews

    VOLUNTARY ANNOUNCEMENT SHARE BUY-BACK PROGRAMME

  8. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 16, 2026

  9. HKEXnews

    INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS

  10. HKEXnews

    VOLUNTARY ANNOUNCEMENT Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026

  11. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  12. HKEXnews

    (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; AND (5) NOTICE OF ANNUAL GENERAL MEETING

  13. HKEXnews

    INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS

  14. HKEXnews

    Notification of 2025 PFIC status

  15. HKEXnews

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025

  16. HKEXnews

    TERMS OF REFERENCE OF THE NOMINATION COMMITTEE

  17. HKEXnews

    VOLUNTARY ANNOUNCEMENT Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025

  18. HKEXnews

    VOLUNTARY ANNOUNCEMENT Publication of Phase 2 ENSURE Study Results in Nature Medicine

  19. HKEXnews

    GRANT OF SHARE OPTIONS

  20. HKEXnews

    SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2024

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2137 on TradingView.

Listing details

Brii Biosciences Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2137, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Brii Biosciences Limited
Ticker
2137
Listing
HKEX
Country or territory
China
Business scope
Biotechnology
ISIN
KYG1645A1094
Other listed symbols
GETTEX:7SS
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.